PHARMAC responds on long-acting inhalers for COPD.
Metcalfe
Scott
S
Dougherty
Sean
S
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D001249:Asthma; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D017277:Drug Approval; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration; D009520:New Zealand; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage; D000069447:Tiotropium Bromide; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide